Corticosteroid Dexamethasone could be a lifeline for COVID-19 patients
The initial Dexamethasone clinical trial outcomes in the UK have demonstrated that the generic corticosteroid medication could present a lifeline
Read more
Respiratory
Reinstated hydroxychloroquine study reveals the dangers of rushed trials
The World Health Organisation (WHO) halted one arm of the hydroxychloroquine COVID-19 Trial at the end of May, only to
Read more
Algernon gets FDA nod for human study of Ifenprodil for COVID-19
Algernon has received the FDA’s approval for the commencement of a Phase 2 and 3 human study of it’s repurposed
Read more
ACTide EDC (Electronic Data Capture) System against COVID-19
Nubilaria, a forward thinking clinical data management company, has released an important announcement for Researchers and Health Professionals in Europe
Read more
Nubilaria provides free EDC for pro bono COVID-19 related ARDS study
Nubilaria is providing it’s innovative ACTide EDC system free in support of a clinical study for COVID-19 related ARDS intensive
Read more
Altasciences completes Gimsilumab Phase I study for ARDS in COVID-19
Canadian Altasciences completes its Phase I study on Gimsilumab to prevent and treat acute respiratory distress syndrome (ARDS) in COVID-19
Read more
EU waiving VAT and customs duty on critical medical devices
The European Commission has waived customs duty and VAT on medical devices imported from non-EU countries. A decision has been
Read more
Roche’s Actemra (tocilizumab) shows “excellent effects” against COVID-19
The widely used arthritis medicine Actemra (tocilizumab) has demonstrated “excellent effects” in the treatment of the COVID-19 disease. Roche’s promising
Read more
Kaletra (lopinavir/ritonavir) disappoints as treatment for severe COVID-19
Kaletra, a medicine containing two HIV drugs, lopinavir and ritonavir, which was considered as a potential treatment for the novel
Read more
FDA grants Emergency Use Authorisation for Roche’s Coronavirus Test
Roche’s coronavirus test has been granted Emergency Use Authorization by the U.S. Food and Drug Administration, the Swiss pharma giant
Read more